Showing 541 - 560 results of 707 for search '(( 10 ((steel decrease) OR (((nn decrease) OR (mean decrease)))) ) OR ( 2020 a decrease ))*', query time: 0.15s Refine Results
  1. 541
  2. 542
  3. 543
  4. 544
  5. 545
  6. 546
  7. 547
  8. 548
  9. 549

    Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data by Alalawneh, Majdoleen

    Published 2023
    “…Results The number of patients initiated on rivaroxaban therapy significantly increased from 152 (3.3%) in 2015 to 1342 (28.9%) in 2020 (p <0.001). Within BMI categories, a similar increasing trend was observed in underweight, normal, and overweight patients, while from 2018 to 2020, there was a decreasing trend in rivaroxaban prescribing in all obese classes. …”
    Get full text
    Get full text
  10. 550
  11. 551
  12. 552
  13. 553
  14. 554
  15. 555
  16. 556
  17. 557

    Trends and Appropriateness of Sodium-glucose Co-transporter 2 Inhibitors Use in Qatar by Zaghloul, Nancy

    Published 2023
    “…Consistently, sulfonylurea prescriptions declined between 2017 and 2020. Empagliflozin prescribing showed an increase over dapagliflozin, which decreased by the end of 2018. …”
    Get full text
  18. 558
  19. 559
  20. 560